TAMs can express CTLA-4 and bind to the CTLA-4 ligands B7.1 and B7.2 on T cells, which inhibits T-cell activation and proliferation.76 This inhibition reduces the killing of tumor cells by T cells, thereby promoting tumor growth. The gene discussed is CD86; the disease is neoplasm.